Virtus Biotech Etf is a ETF series of ETFis Series Trust I (series S000047354). Net assets $59.3M as of 2026-04-30. Index fund.
Showing 15 of 63 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| IMMUNITYBIO INC | — | $2.8M | 480.22% |
| DREYFUS GOVERNMENT CASH MANAGE | DGCXX | $1.9M | 315.10% |
| APELLIS PHARMACEUTICALS INC | — | $1.5M | 259.07% |
| KALVISTA PHARMACEUTICALS INC | — | $1.5M | 251.65% |
| MODERNA INC | — | $1.5M | 248.90% |
| IOVANCE BIOTHERAPEUTICS INC | — | $1.4M | 243.79% |
| MIRUM PHARMACEUTICALS INC | — | $1.4M | 238.94% |
| AXSOME THERAPEUTICS INC | — | $1.3M | 223.77% |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | $1.2M | 206.40% |
| ROIVANT SCIENCES LTD | — | $1.2M | 206.06% |
| ZAI LAB LTD | — | $1.2M | 194.38% |
| LIGAND PHARMACEUTICALS | — | $1.1M | 193.20% |
| BIOCRYST PHARMACEUTICALS INC | — | $1.1M | 193.15% |
| TRAVERE THERAPEUTICS INC | — | $1.1M | 193.03% |
| NOVAVAX INC | — | $1.1M | 192.54% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $59.3M |
| 2026-01-30 | $44.9M |
| 2025-10-31 | $29.8M |
| 2025-07-31 | $24.6M |
| 2025-04-30 | $23.6M |
| 2025-01-31 | $21.8M |
| 2024-10-31 | $22.1M |
| 2024-07-31 | $22.0M |